Annual Total Debt
$21.05 M
+$15.79 M+300.30%
December 31, 2023
Summary
- As of February 25, 2025, VRDN annual total debt is $21.05 million, with the most recent change of +$15.79 million (+300.30%) on December 31, 2023.
- During the last 3 years, VRDN annual total debt has risen by +$20.59 million (+4525.93%).
- VRDN annual total debt is now -20.90% below its all-time high of $26.61 million, reached on December 31, 2013.
Performance
VRDN Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$21.11 M
+$154.00 K+0.73%
September 30, 2024
Summary
- As of February 25, 2025, VRDN quarterly total debt is $21.11 million, with the most recent change of +$154.00 thousand (+0.73%) on September 30, 2024.
- Over the past year, VRDN quarterly total debt has increased by +$291.00 thousand (+1.40%).
- VRDN quarterly total debt is now -20.66% below its all-time high of $26.61 million, reached on December 31, 2013.
Performance
VRDN Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
VRDN Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +300.3% | +1.4% |
| 3 y3 years | +4525.9% | +1.4% |
| 5 y5 years | +104.4% | +1.4% |
VRDN Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3947.7% | at high | +3960.0% |
| 5 y | 5-year | at high | +4525.9% | at high | +5847.0% |
| alltime | all time | -20.9% | -100.0% | -20.7% | -100.0% |
Viridian Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $21.11 M(+0.7%) |
| Jun 2024 | - | $20.96 M(-0.5%) |
| Mar 2024 | - | $21.06 M(+0.1%) |
| Dec 2023 | $21.05 M(+300.3%) | $21.05 M(+1.1%) |
| Sep 2023 | - | $20.82 M(+277.8%) |
| Jun 2023 | - | $5.51 M(+3.7%) |
| Mar 2023 | - | $5.31 M(+1.1%) |
| Dec 2022 | $5.26 M(+911.2%) | $5.26 M(+1.6%) |
| Sep 2022 | - | $5.18 M(+0.2%) |
| Jun 2022 | - | $5.17 M(+792.1%) |
| Mar 2022 | - | $579.00 K(+11.3%) |
| Dec 2021 | $520.00 K(+14.3%) | $520.00 K(+20.9%) |
| Sep 2021 | - | $430.00 K(+4.4%) |
| Jun 2021 | - | $412.00 K(+16.1%) |
| Mar 2021 | - | $355.00 K(-22.0%) |
| Dec 2020 | $455.00 K(-94.5%) | $455.00 K(-95.1%) |
| Sep 2020 | - | $9.24 M(+0.5%) |
| Jun 2020 | - | $9.19 M(+19.8%) |
| Mar 2020 | - | $7.67 M(-7.6%) |
| Dec 2019 | $8.30 M(-19.4%) | $8.30 M(-10.0%) |
| Sep 2019 | - | $9.23 M(-9.1%) |
| Jun 2019 | - | $10.15 M(-2.3%) |
| Mar 2019 | - | $10.39 M(+0.9%) |
| Dec 2018 | $10.30 M | $10.30 M(+0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $10.21 M(+0.9%) |
| Jun 2018 | - | $10.11 M(+0.9%) |
| Mar 2018 | - | $10.02 M(+1.0%) |
| Dec 2017 | $9.92 M(+849.5%) | $9.92 M(+194.1%) |
| Sep 2017 | - | $3.37 M(-12.4%) |
| Jun 2017 | - | $3.85 M(-10.9%) |
| Mar 2017 | - | $4.32 M(+313.5%) |
| Dec 2016 | $1.04 M(-5.4%) | $1.04 M(-5.4%) |
| Sep 2016 | - | $1.10 M(0.0%) |
| Jun 2016 | - | $1.10 M(0.0%) |
| Mar 2016 | - | $1.10 M(0.0%) |
| Dec 2015 | $1.10 M(>+9900.0%) | $1.10 M(0.0%) |
| Sep 2015 | - | $1.10 M(0.0%) |
| Jun 2015 | - | $1.10 M(+4.4%) |
| Mar 2015 | - | $1.06 M(>+9900.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2014 | - | $10.60 K(0.0%) |
| Jun 2014 | - | $10.60 K(-98.9%) |
| Mar 2014 | - | $1.01 M(-96.2%) |
| Dec 2013 | $26.61 M(+17.6%) | $26.61 M(>+9900.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00 |
| Dec 2012 | $22.63 M | - |
FAQ
- What is Viridian Therapeutics annual total debt?
- What is the all time high annual total debt for Viridian Therapeutics?
- What is Viridian Therapeutics annual total debt year-on-year change?
- What is Viridian Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly total debt year-on-year change?
What is Viridian Therapeutics annual total debt?
The current annual total debt of VRDN is $21.05 M
What is the all time high annual total debt for Viridian Therapeutics?
Viridian Therapeutics all-time high annual total debt is $26.61 M
What is Viridian Therapeutics annual total debt year-on-year change?
Over the past year, VRDN annual total debt has changed by +$15.79 M (+300.30%)
What is Viridian Therapeutics quarterly total debt?
The current quarterly total debt of VRDN is $21.11 M
What is the all time high quarterly total debt for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly total debt is $26.61 M
What is Viridian Therapeutics quarterly total debt year-on-year change?
Over the past year, VRDN quarterly total debt has changed by +$291.00 K (+1.40%)